EastPharma : EP DEVA 9M 2017 IRCall

PHILIPP HAAS - CHAIRMAN & CEO MESUT CETIN - DIRECTOR & CFO

2

• The period end USD/TRY exchange rate increased by 0.93%; 3.5192 as of 31 December 2016, 3.5521 as of 30 September 2017.

• The average USD/TRY exchange rate strengthened by 22.6%; 2.9309 for

3.6386

3.5521

3.5192

3.5071

2.9959

3.8

3.6

3.4

3.2

3.0

2.8

2.6

2.4

2.2

2.0

3.6356

3.5936

2.9309

9M 2016, 3.5936 for 9M 2017.

3.6928

3.8

3.6

3.4

3.2

3.0

2.8

2.6

2.4

2.2

2.0

2.9409

2.9181

2

3

• Revenues in 9M 2017 reached to US$ 163.5mn (TRY 588.3mn) vs US$

  172.6mn (TRY 505.4mn) in 9M 2016.

  • 5.3% year-on-year decrease in US$

  • 16.4% year-on-year increase in TRY

Revenues : ($, mn)

209.9

224.9

172.6

163.5

2015

2016

9M'16

9M'17

3

4

Human Pharma Veterinary Goods Other

6.3%

1.2%

92.5%

Domestic Sales

Export Sales

6.9%

93.1%

4